NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/10/2024
Back to search
Official data from USPTO
EXACTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXACTIS
ST13
US500000086534923Class
35, 36, 42, 44
Filing
86534923
Registration
5505700
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
12/10/2024
Trademark type
Word
Nice classes
35, 36, 42, 44
Filing date
02/13/2015
Registration date
07/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
12/10/2024
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Montréal, Québec, CA
Examiner
LAW, CHRISTOPHER
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
I. E. (pessoa física)
I. E. (pessoa física)
Representatives
Christie Baty Hudgins Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Technical classification
Nice Classes
Class 35Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting collaboration and the exchange of information and resources within the scientificresearchmedicalclinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatment
Class 36
Financial sponsorship of clinical and translational trials in the field of cancer treatment
Class 42
Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing research information in the nature of medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of cancer treatment for others; Providing clinical trial information in the nature of research data pertaining to cancer
Class 44
Providing medical information with profiles of cancer patients' tumours and the associated clinical and molecular datacancer drugsbiomarkersbiological and tissue samplesresults of clinical studiesvia an on-line searchable database; Providing tissue biobank servicesaccess to a biobank of human biological and tissue samples; Providing medical information concerning quality of life in the fields of the treatment of cancerthe likelihood of success of the treatment of cancerthe physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; Providing medical information in the nature of medical data pertaining to cancer and its treatment; Providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; Providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment
Publications
History of USPTO decisions and trademark events.
48 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/02/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/14/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/14/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/05/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2018
PUBO
PUBLISHED FOR OPPOSITION
04/17/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2017
GNRT
NON-FINAL ACTION E-MAILED
09/13/2017
CNRT
NON-FINAL ACTION WRITTEN
09/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2017
ALIE
ASSIGNED TO LIE
08/14/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/18/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/10/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/10/2017
CNSI
SUSPENSION INQUIRY WRITTEN
05/10/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/04/2016
GNSL
LETTER OF SUSPENSION E-MAILED
11/04/2016
CNSL
SUSPENSION LETTER WRITTEN
11/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/03/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/04/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/04/2016
CNSI
SUSPENSION INQUIRY WRITTEN
05/04/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/03/2015
GNSL
LETTER OF SUSPENSION E-MAILED
11/03/2015
CNSL
SUSPENSION LETTER WRITTEN
11/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/21/2015
GNRT
NON-FINAL ACTION E-MAILED
05/21/2015
CNRT
NON-FINAL ACTION WRITTEN
05/21/2015
DOCK
ASSIGNED TO EXAMINER
05/20/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2015
NWAP
NEW APPLICATION ENTERED
02/17/2015
Continuous trademark protection
Get notified about every new filing that threatens EXACTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.